1. Home
  2. RLTY vs SMTI Comparison

RLTY vs SMTI Comparison

Compare RLTY & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest

RLTY

Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest

HOLD

Current Price

$14.44

Market Cap

262.5M

Sector

Finance

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$35.05

Market Cap

313.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RLTY
SMTI
Founded
2022
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
262.5M
313.5M
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
RLTY
SMTI
Price
$14.44
$35.05
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$34.00
AVG Volume (30 Days)
44.1K
220.8K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
9.35%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$15,586,976.00
Revenue This Year
N/A
$17.31
Revenue Next Year
N/A
$12.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.47
52 Week Low
$14.04
$16.05
52 Week High
$16.41
$35.34

Technical Indicators

Market Signals
Indicator
RLTY
SMTI
Relative Strength Index (RSI) N/A 73.84
Support Level N/A $33.99
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.24
MACD 0.00 -0.18
Stochastic Oscillator 0.00 83.33

Price Performance

Historical Comparison
RLTY
SMTI

About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest

Cohen & Steers Real Estate Opportunities and Income Fund is a non-diversified, closed-end management statutory trust. Its primary investment objective is high current income. Its secondary investment objective is capital appreciation. The fund invests the majority of its managed assets in real estate-related investments and preferred and other income securities.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: